NYSE:KKR

KKR Announces Completion of Acquisition of Simon & Schuster from Paramount

Retrieved on: 
星期一, 十月 30, 2023
Publishing, Finance, Banking, Communications, Professional Services, Paramount Global, KKR, Family, Acquisition, Paramount, Simon & Schuster, Growth, Book, Media

KKR, a leading global investment firm, today announced the successful completion of the previously announced acquisition of Simon & Schuster from Paramount Global (NASDAQ: PARA, PARAA) in a $1.62 billion all-cash transaction.

Key Points: 
  • KKR, a leading global investment firm, today announced the successful completion of the previously announced acquisition of Simon & Schuster from Paramount Global (NASDAQ: PARA, PARAA) in a $1.62 billion all-cash transaction.
  • I know that we will build on that legacy going forward.”
    “Today, Simon & Schuster and KKR are officially one family.
  • We are thrilled to work on the next phase of Simon & Schuster’s growth with Jon and the entire Simon & Schuster team.
  • “After a highly competitive process, this is an ideal outcome for both Simon & Schuster and Paramount.

KKR to Invest $400 Million in Leading Neutral Subsea Telecommunications Cable Services Provider OMS Group

Retrieved on: 
星期一, 十月 30, 2023
Mobile, Wireless, Technology, Finance, Other Technology, Telecommunications, Professional Services, Networks, Internet, Data Management, IOT (Internet of Things), OM Group, OMS, KKR, Acquisition, Multimedia, Growth, CyrusOne, Investment, Asset management, Singtel

KKR, a leading global investment firm, and the parent company of OMS Group (or the “Company”), a leading telecom infrastructure company and provider of subsea cable services, today announced the signing of definitive agreements under which KKR will commit $400 million in a tailored solution for OMS Group.

Key Points: 
  • KKR, a leading global investment firm, and the parent company of OMS Group (or the “Company”), a leading telecom infrastructure company and provider of subsea cable services, today announced the signing of definitive agreements under which KKR will commit $400 million in a tailored solution for OMS Group.
  • View the full release here: https://www.businesswire.com/news/home/20231029552367/en/
    Founded in 1988, OMS Group is a neutral provider of integrated solutions for subsea telecommunications cable services, including installation and maintenance projects.
  • KKR’s investment positions OMS Group well to accelerate its growth, including through expanding its fleet size and capabilities and investing in cable landing stations and subsea cable routes to serve global fast-growing cross-border data transmission trends and the demand for comprehensive subsea cable services.
  • We look forward to sharing our global network and infrastructure expertise to take OMS Group to its next stage of growth.”
    Datuk Soon Foo Lim, OMS Group’s Chairman, said, “OMS Group and KKR share the same vision and appreciation of the critical data infrastructure OMS Group builds and maintain for its clients.

Clinisupplies Acquires Aquaflush TAI Portfolio to Continue Building a Leading Chronic Care Organisation

Retrieved on: 
星期四, 十月 26, 2023
Medical Devices, Medical Supplies, Hospitals, Professional Services, Health, General Health, Retail, Asset Management, Supply Chain Management, NHS, Acquisition, Patient, Visiting Nurse Service of New York, KKR, Nursing

Clinisupplies Limited (“Clinisupplies”), a leading manufacturer and supplier of continence care consumables, today announced the acquisition of the Aquaflush transanal irrigation (“TAI”) business from Renew Medical Inc. and Renew Medical UK Limited, a US and UK manufacturer of continence products (together “Renew”).

Key Points: 
  • Clinisupplies Limited (“Clinisupplies”), a leading manufacturer and supplier of continence care consumables, today announced the acquisition of the Aquaflush transanal irrigation (“TAI”) business from Renew Medical Inc. and Renew Medical UK Limited, a US and UK manufacturer of continence products (together “Renew”).
  • The acquisition of the Aquaflush TAI range will enable Clinisupplies to expand its offering to include bowel management products, while also supporting patients living with chronic bowel issues through its nursing services.
  • Clinisupplies continues to integrate fast growing businesses, strengthening its position as a leading UK based direct-to-consumer chronic care company, providing continence care products and nursing services that helps support the NHS.
  • KKR has a long track record of supporting health care companies globally, having invested approximately $19 billion in the sector since 2004.

KKR to Invest in Precipart to Accelerate Growth

Retrieved on: 
星期二, 十月 24, 2023
Consulting, Banking, Aerospace, Manufacturing, Professional Services, Health, Business, Medical Devices, Other Manufacturing, Engineering, Finance, Family, Growth, Original equipment manufacturer, Partnership, KKR, Multimedia, Pharmaceutical industry

KKR, a leading global investment firm, announced today that it has agreed to invest in Precipart (the “Company”), a leading contract manufacturer of precision components for the medical device and aerospace industries.

Key Points: 
  • KKR, a leading global investment firm, announced today that it has agreed to invest in Precipart (the “Company”), a leading contract manufacturer of precision components for the medical device and aerospace industries.
  • KKR plans to support the Company in its continued growth organically and through M&A.
  • The Laubscher family remains highly committed to Precipart and is retaining a significant minority ownership stake in the Company.
  • Oliver Laubscher, CEO of Precipart, commented: “My family and I are thrilled to form this strategic partnership with KKR.

KKR & Co. Inc. to Announce Third Quarter 2023 Results

Retrieved on: 
星期三, 十月 18, 2023
Asset Management, Professional Services, Insurance, Finance, KKR, NYSE, Internet, Cryptocurrency

KKR & Co. Inc. (NYSE: KKR) announced today that it plans to release its financial results for the third quarter 2023 on Tuesday, November 7, 2023, before the opening of trading on the New York Stock Exchange.

Key Points: 
  • KKR & Co. Inc. (NYSE: KKR) announced today that it plans to release its financial results for the third quarter 2023 on Tuesday, November 7, 2023, before the opening of trading on the New York Stock Exchange.
  • A conference call to discuss KKR’s financial results will be held on Tuesday, November 7, 2023 at 10:00 a.m.
  • Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR’s website at https://ir.kkr.com/events-presentations/ .
  • A replay of the live broadcast will be available on KKR’s website beginning approximately one hour after the broadcast.

KKR Closes Third Tech Growth Fund at Nearly $3 Billion

Retrieved on: 
星期三, 十月 18, 2023
Banking, Asset Management, Professional Services, Finance, OutSystems, Darktrace, Insurance, KKR, Environment, Partner, Fund, AI, Investment, NGT, Renewable energy

KKR, a leading global investment firm, today announced the final close of KKR Next Generation Technology Growth Fund III (“NGT III” or the “Fund”), an approximately $3 billion fund focused on investing in leading growth technology companies across North America, Europe and Israel.

Key Points: 
  • KKR, a leading global investment firm, today announced the final close of KKR Next Generation Technology Growth Fund III (“NGT III” or the “Fund”), an approximately $3 billion fund focused on investing in leading growth technology companies across North America, Europe and Israel.
  • We’ve seen firsthand that innovation is a critical driver of investment returns,” said Dave Welsh, KKR Partner & Global Head of Tech Growth.
  • We see significant opportunity to continue partnering with the entrepreneurs leading these businesses and helping them achieve their growth ambitions,” said Stephen Shanley, Partner & Head of Tech Growth, Europe.
  • The Firm has executed several transactions as part of its tech growth strategy, including DarkTrace , KnowBe4 , 09 , Onestream , OutSystems , NetSPI and Restaurant365 .

KKR to Invest in Life Sciences Firm Catalio Capital Management

Retrieved on: 
星期二, 十月 17, 2023
Professional Services, Health, Other Professional Services, Other Health, Finance, Asset Management, MSD, Dow Chemical Co. v. United States, Investment, Partnership, Central Waqf Council, Multimedia, Acquisition, Goldman Sachs, LLP, Dow Chemical Company, Partner, Johnson & Johnson, Entrepreneurship, BDT, LP, Paul, Weiss, Rifkind, Wharton & Garrison, Kirkland & Ellis, KKR, Biomedical technology, Management, Pharmaceutical industry

KKR, a leading global investment firm, today announced an agreement to invest in Catalio Capital Management, LP, a multi-strategy investment firm focused on breakthrough biomedical technology and innovative health care companies.

Key Points: 
  • KKR, a leading global investment firm, today announced an agreement to invest in Catalio Capital Management, LP, a multi-strategy investment firm focused on breakthrough biomedical technology and innovative health care companies.
  • The addition of new capital is expected to accelerate Catalio’s growth trajectory and talent acquisition, as well as anchor its investment strategies.
  • Pursuant to the agreement, KKR is acquiring a minority economic stake in Catalio and will invest in Catalio’s funds.
  • “The life sciences sector represents a growing market opportunity and has been an important area of focus for our health care growth strategy, which will be further accelerated through our partnership with Catalio.

KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma

Retrieved on: 
星期一, 十月 16, 2023
Professional Services, Health, Asset Management, Research, Science, Pharmaceutical, Biotechnology, Partnership, Diane Fleri, DACH, Drug development, Therapy, Diversified Pharmaceutical Services, Divisional patent application, KKR, Fine chemical, Frontier, Recipharm, Coriolis

KKR, a leading global investment firm, today announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions (“Frontier”), which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers.

Key Points: 
  • KKR, a leading global investment firm, today announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions (“Frontier”), which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers.
  • Frontier will invest in differentiated scientific capabilities and proprietary technology platforms that address critical bottlenecks in the development and manufacturing of advanced therapeutics.
  • As the platform’s foundational investment, funds managed by KKR and Flerie, through Frontier, have invested in Munich-based Coriolis Pharma, a global leader in formulation research and development, analytical services and non-GMP manufacturing of innovative high-value biologics and cell and gene therapy products.
  • “Coriolis Pharma has an industry-leading track record as a global provider of mission-critical, highly specialized formulation development services and a reputation for scientific leadership and complex problem solving.

KKR Expands Operations in India With New Gurugram Office

Retrieved on: 
星期三, 十月 4, 2023
Finance, Banking, Professional Services, Asset Management, Insurance, Workforce, University, BlackRock, KKR, City, Film industry

Leading global investment firm KKR today announced it is expanding its operations in India with the opening of a new office in Gurugram.

Key Points: 
  • Leading global investment firm KKR today announced it is expanding its operations in India with the opening of a new office in Gurugram.
  • We are delighted to be part of the Gurugram business community.”
    KKR expects to welcome approximately 150 new employees in Gurugram by early 2024, initially including finance, operations, human capital and technology talent by the end of the year.
  • Ms. Awasthi joins KKR after spending nearly two decades at BlackRock, where she was most recently Head of Financial Markets Advisory at BlackRock India, also based in Gurugram.
  • KKR has long had a presence in India, having opened its first location in Mumbai in 2009.

KKR Sells Over $560 Million of U.S. Industrial Real Estate

Retrieved on: 
星期一, 十月 2, 2023
Professional Services, Insurance, Commercial Building & Real Estate, Finance, Construction & Property, Asset Management, Banking, Lehigh Valley, Sale, Knowledge, Growth, SF, KKR, Investment, Real estate, Financial services, South Central Pennsylvania

KKR, a leading global investment firm, today announced that KKR has completed the sale of over 5 million square-feet (SF) of industrial warehouse and distribution properties for a total aggregate value of over $560 million.

Key Points: 
  • KKR, a leading global investment firm, today announced that KKR has completed the sale of over 5 million square-feet (SF) of industrial warehouse and distribution properties for a total aggregate value of over $560 million.
  • The sales, primarily consisting of assets in KKR’s Real Estate Partners Americas II fund, included over 50 industrial buildings located in high-growth, infill markets across Atlanta, Dallas-Fort Worth, Chicago, the Lehigh Valley and Central Pennsylvania.
  • Including these five sales, KKR has sold approximately 21 million SF since 2021 and currently owns over 40 million SF of industrial real estate in major metropolitan areas.
  • “These sales demonstrate the attractive bid that exists for a quality assets in supply-constrained locations.”
    KKR’s global real estate business invests in high-quality, thematic real estate through a full range of scaled equity and debt strategies.